Search results for “Management of Crohn's disease” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 22 patents, we discovered top 17 key players by total patent application. Alfagene Bioscience, Inc., Novartis AG, Boehringer Ingelheim International GmbH are dominant in this area. They take 40.91% of the total patent filing.
Alfagene Bioscience, Inc.
United States
Patent: 5
Novartis AG
Basel-Stadt, Switzerland
Patent: 2
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 2
Tianjin Hemay Pharmaceutical Technology Co., Ltd.
Tianjin Shi, China
Patent: 2
Ganzhou Hemay Pharmaceutical Co Ltd
United States
Patent: 2
Resonac Corp.
Tokyo-to, Japan
Patent: 1
Torii Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 1
Genentech, Inc.
California, United States
Patent: 1
Southwest Pharmaceutical Group Co. Ltd.
Chongqing Shi, China
Patent: 1
Ed Geistlich Söhne AG Für Chemische Industrie
ZURICH, Switzerland
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
No data, please try another search term
New Entrants
Order by:
Innovation in recent 5 years
No data, please try another search term
Research Institutions
Order by:
Innovation Intensity
With the analysis among 6 patents, we discovered top 3 universities and scientific research institutions by total patent application.
University of Zurich
ZURICH, Switzerland
Patent: 2
Université d'Auvergne
France
Patent: 1
Universidad de Alcalá
Spain
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: